We tested the hypothesis that the vasocon striction produced by the application of blood to the ad ventitial surfaces of the vessels of an isolated perfused canine circle of Willis preparation was mediated by products of prostaglandin metabolism. In this preparation (perfused at constant flow and outflow pressure), topical application of blood produced an average 16.6 ± 1.8 (SE) mm Hg increase in inflow pressure. This response could be prevented with four structurally dissimilar cyclooxy genase inhibitors (aspirin, indomethacin, ibuprofen, and meclofenamate), suggesting that the blood-induced in crease in vascular resistance was mediated by prosta-
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vasoconstriction has been produced experimentally by the application of fresh blood to exposed cere bral arteries in situ (Echlin, 1965) or in vitro (Linder and Alksne, 1978) , by artificial rupture of the cerebral arteries in vivo (Brawley et al., 1968; Nagai et al., 1974) , and by the injection of blood into the subarachnoid space (Echlin, 1971; Pennink et al., 1972; Walker et al., 1983; White and Rob ertson, 1983) . In addition, an exact correspondence has been reported between the site of major sub arachnoid blood clots and the location of severe vascular spasm in patients with subarachnoid hem orrhage (Fisher et al., 1980) .
Recently, it has been suggested that prosta glandins may mediate the blood-induced spasm. This suggestion is based on evidence that prosta glandin concentrations are elevated in the cerebro spinal fluid and blood vessels of animals with ex perimentally induced hemorrhage (Maeda et al., 1981; Walker et al., 1983) . Additionally, it has been reported that the cisternal administration of exoge nous prostaglandins can produce cerebral vascular spasm (Pennink et al., 1972; White et al., 1975) and that some cyclooxygenase inhibitors are effective in attenuating the cerebral spasm that occurs after cisternal blood administration (White et aI. , 1979; White and Robertson, 1983) . There is thus reason to believe that alterations in prostaglandin metabo lism may be involved in the development of the vascular spasm that occurs after cerebral hemor rhage.
We have recently developed an isolated canine circle of Willis preparation in which the cerebral ar teries of an isolated canine brain are perfused with Krebs-Henseleit buffer at a constant flow rate and outflow pressure. In this preparation (unpublished observations), the application of autologous blood to the adventitial surfaces of the perfused vessels produces an acute increase in vascular resistance that is manifested as an increase in inflow (arterial) pressure. The purpose of this study was to test the hypothesis that the cerebral vasoconstriction pro duced by blood in this preparation is mediated by prostaglandins.
MATERIALS AND METHODS

Isolated perfused circle of Willis preparation
Experiments were done on 44 mongrel dogs (21.5 ± 4.0 kg, mean ± SD) of either sex. Each animal was anes thetized with thiamyl sodium (Bio-tal; 18 mglkg, i.v.). Heparin (1,000 U/kg, i.v.) was administered to prevent blood coagulation, and the animal was exsanguinated through a large bore polyethylene cannula inserted into the femoral artery. The first 500-I ,000 ml of blood was collected for the superfusion system. The blood was stirred and maintained at 37°C until it was used in the experiment.
In the first third of our experiments, the blood was stored in untreated glass or plastic containers. In later experiments, the containers were siliconized with a prep aration of 5% dichlorodimethylsilane (Sigma Chemical Co., St. Louis, MO, U.S.A.) to insure that formed cel lular elements of the blood did not react with the un treated surface of the glassware (Cutts, 1970) . No dif ferent responses were observed, however, in experiments in which the blood was stored in untreated or in silicon ized glassware.
During exsanguination, the dorsal calvarium and the dura mater were removed. After the bleeding stopped, the brain was removed by transecting the medulla, the basilar and internal carotid arteries, and the second and third cranial nerves. Each brain was placed in a container filled with modified Krebs-Henseleit buffer solution (118. 1 mM NaCI, 4.7 mM KCI, 1.2 mM MgS0 4 ' 7H20, 1.2 mM KP0 4 , 2.5 mM CaCI . 2H20, 25 mM NaHC0 3 , 11.1 mM dextrose) equilibrated with a gas mixture of 95% O2 and 5% CO2, The caudal cerebral and rostral cere bellar arteries were ligated, and the basilar artery was cannulated with a 22-gauge Angiocath intravenous cath eter placement unit (Deseret, Sandy, UT, U.S.A.). Ap proximately 20 min elapsed between the time of the an imal's death and the start of perfusion of the arteries.
A Gilson Minipuls peristaltic pump was used to pump modified Krebs-Henseleit buffer at a constant flow rate (25.8 ± 2.8 mllmin, mean ± SD) from a beaker, through a membrane oxygenator (SciMed Life Systems, Minne- 1988 apolis, MN. U.S.A.), where the perfusate was equili brated with 95% O2 and 5% CO2, and through a heat ex changer to warm the perfusate to 37°C. The perfusate flowed into the basilar artery, through the posterior com municating arteries, and then out the transected internal carotid arteries. Outflow pressure was thus atmospheric pressure in all experiments. A pressure tap was placed just proximal to the cannulated basilar artery to measure inflow pressure. At the beginning of each experiment, in flow pressure (average 70.8 ± 11.0 mm Hg) was set by adjusting the pump flow rate. The mean inflow pressure was less than normal arterial pressure, as only the large cerebral arteries and no-resistance vessels were per fused. Unusually high flow rates would have been re quired to obtain normal arterial pressures.
Under control conditions, buffer solution was also su perfused onto the cerebral arteries at a rate of 6.2 mllmin, using a Harvard infusion pump. The composition of the superfusate solution could be changed by turning the stopcocks on a manifold system to allow blood or other vasoactive substances to be delivered to the adventitial surface of the cerebral arteries.
Preliminary experiments
In four experiments, papaverine HCI (Sigma) was ad ministered to determine if a smooth muscle relaxant could reverse the blood-induced increase in vascular re sistance. In these experiments, a manifold system was used to allow either blood or blood containing 90 mg/dl papaverine HCI to be superfused onto the cerebral ar teries. In each experiment, blood was first superfused onto the vessels to produce an increase in inflow pres sure. At the peak of the response, the superfusate was switched so that the blood containing papaverine was ad ministered to the vessels.
We performed two types of studies to rule out the pos sibility that the blood-induced constriction was an artifact of the blood storage procedures used in this study. In one experiment, we compared the effect of blood stored for 1 h with that of fresh blood pumped from a donor dog. We first superfused the cerebral arteries of the preparation with stored autologous blood that had been stirred and heated to 37°C in order to demonstrate the vessels' reac tivity to blood. After an increase in inflow pressure was obtained, the vessels were superfused with buffer to allow them to recover. After inflow pressure returned to baseline, fresh heparinized arterial blood pumped from a cannulated femoral artery of an anesthetized donor dog was superfused onto the vessels at a rate of 6.2 mllmin. During this time, the arterial pressure of the donor dog was monitored from a cannula placed in the other femoral artery. In two experiments, the ability of heparin to cause vasoconstriction was evaluated by superfusing the vessels with buffer containing heparin in the plasma con centrations l250 U/ml) used in this study.
Prostaglandin cascade inhibition
Prostaglandin synthesis was inhibited at two different points of the prostaglandin cascade. In the first group of experiments, either aspirin (Sigma; n = 6), indomethacin (Sigma; n = 5), ibuprofen (Sigma; n = 6), or meclofena mate (Parke-Davis, Ann Arbor, MI, U.S.A.; n = 6) was used to inhibit cyc!ooxygenase. In four animals, imid azole (Sigma), an inhibitor of thromboxane synthetase, was used to prevent the possible formation of throm boxane, a potent vasoconstrictor prostaglandin. The protocol for these experiments is shown in Ta ble I.
Once the preparation was set up, the blood vessels were perfused and superfused with the buffer solution for ap proximately 45 min to allow the preparation to stabilize. In each experiment, blood was superfused onto the vessels three times. In the first trial (Control I), blood was administered to demonstrate the reactivity of the vessels. In the second trial (treatment condition), an at tempt was made to prevent the blood-induced vasocon striction with one of the above inhibitors. Finally, in the third trial (Control 2), the inhibitor was washed out of the system, and the response to blood was reevaluated. Each blood application was followed by superfusion of the buffer solution to reestablish a baseline inflow pressure. For the second trial, both the perfused buffer and the su perfused blood were mixed with the inhibitor drug. The vessels were perfused with the buffer containing the in hibitor for 19-39 min before superfusing the vessels with blood. The following drug concentrations were used for both buffer and blood: aspirin (10-3 M), indomethacin (10-6 M), ibuprofen (10-4 M), meclofenamate (10-4 M),
and imidazole (four trials, 5.5 x 10-4 M; one trial, 5.5 x 10-3 M). These drugs were dissolved directly in the buffer solution or blood. The cyclooxygenase inhibitor concentrations were chosen to approximate the plasma concentrations of these drugs obtained after therapeutic administration.
To test whether or not the cyclooxygenase inhibitors in the concentrations used blocked the constriction caused by drugs that increased resistance by a mechanism not involving prostaglandin formation, we evaluated both the ability of all four inhibitors (in one experiment each) to prevent the pressor response of serotonin (10-3 M) and the ability of meclofenamate in one experiment to pre vent the pressor response of PGF20< (10-5 M).
Response to arachidonic acid
Arachidonic acid (Sigma) was administered to five preparations. Five hundred milligrams arachidonic acid was dissolved in 100 ml of 18% ethanol in 100 mM NaC0 3 under nitrogen and then frozen. On the day of the experi ment, the solution was thawed and diluted with buffer solution to a final concentration of 3.2 x 10-5 M. Two trials were done in each experiment, and between trials, buffer was superfused to allow the vessels to recover. In the first trial, blood was superfused to provide a refer ence pressor response. After baseline pressures were reattained, arachidonic acid was superfused onto the vessels. Superfusion of the ethanol-NaCO} vehicle alone had no effect on vascular tone. and PGF20< (10-5 M; Upjohn) were dissolved in buffer so lution and superfused onto the vessels to test the ability of these substances to produce constriction. In each of the six experiments, the pressor response to whole blood was determined first. After baseline pressures were reat-tained by application of the buffer solution, PGE2 and PGF20< were sequentially applied in a random order. Buffer was superfused between administration of the two prostaglandins to allow the vessels to recover.
Statistics
The data were analyzed by analysis of variance for re peated measures. Where significant effects were found, a further analysis was made of the treatment means using the least significant difference test.
RESULTS
The topical application of blood to the adventitial surface of the cerebral arteries produced an average increase in inflow pressure of 16.6 ± 1.8 (SE) mm Hg. The range of increases varied between 4 and 67 mm Hg. A representative pressure tracing is shown in Fig. 1 , which also shows that the increase in in flow pressure could be eliminated by the adminis tration of papaverine. In the four experiments in which papaverine was administered at the peak of the response, blood superfusion caused inflow pressure to rise from 71.0 ± 2.8 (SE) to 88.0 ± 2.3 mm Hg (p < 0. 05). When the superfusate was switched so that papaverine mixed in blood was ad ministered to the vessels, inflow pressure promptly fell to baseline (68.5 ± 3. 2 mm Hg, p < 0.05). Al most identical increases in inflow pressure were observed in the one experiment in which the cere bral vascular responses to stored blood and fresh blood pumped from a donor dog were compared. To pical application of stored blood increased inflow pressure 17 mm Hg, whereas fresh donor blood in creased pressure by 18 mm Hg. Heparin, applied directly to the cerebral arteries, produced no change in inflow pressure in one experiment and a 1 mm Hg increase in the second experiment.
The results of a typical experiment in which aspirin was administered are shown in Fig. 2 . The first panel shows a blood-induced pressor response. The increase in pressure was almost completely prevented (second panel) when aspirin was mixed into the perfusate (buffer solution) and the superfu sate (blood). After the aspirin was washed out of the cerebral arteries, superfused blood again pro duced an increase in inflow pressure (third panel). Ibuprofen, meclofenamate, and indomethacin were also effective in preventing the increase in inflow pressure caused by the topical application of blood (Fig. 3) . It was also possible to reobtain an increase in inflow pressure with blood after washing these inhibitors out of the system. None of the cyclooxy genase inhibitors blocked the ability of serotonin to constrict the vessels. In the presence of either aspirin, meclofenamate, ibuprofen, or indometh acin, serotonin increased inflow pressure by 10, 4, 7, and 20 mm Hg, respectively. In the experiment with meclofenamate, PGF2a produced a 7 mm Hg increase in pressure. Imidazole had no effect on the ability of blood to increase inflow pressure at any dose. Arachidonic acid produced an increase in in flow pressure that was comparable to that produced by blood ( Fig. 4) . PGE2 and PGF2a administration both increased inflow pressure ( Table 2) .
DISCUSSION
The ability of papaverine, a smooth muscle re laxant, to rapidly reverse the blood-induced in crease in inflow pressure observed in this prepara tion indicated that this response was mediated by an increase in vasomotor tone of the cerebral vessels. We have previously found that these vessels will also constrict when known vasocon strictor agents (e.g., serotonin, catecholamines) are applied and dilate when vasodilators (e. g., high concentrations of indomethacin) are applied to the vessels (unpublished data). Ta ken together, these observations indicate that the vessels of this prepa- 1988 ration are responsive to vasoactive stimuli. Addi tionally, the increase in inflow pressure observed after arachidonic acid administration indicated that the endothelium of this preparation was function ally intact, as arachidonate-induced constriction of canine basilar arteries has been shown to be endo thelium-dependent (Katusic et aI., 1987) . [This re sponse is contrasted to the endothelium-dependent relaxation produced by arachidonic acid in other canine arteries (De May et aI., 1982) .] For the cur rent study, it was also important to rule out the pos sibility that the blood-induced vasoconstriction re sulted from the production of unusual vasoactive substances while the blood was stored. In this re gard, we still obtained a response to blood after sil iconizing all glassware and when the vessels were superfused with fresh blood that was pumped out of a donor dog. Finally, the possibility that heparin might have vasoactive properties was ruled out by the observation that superfusion of the buffer mixed with heparin produced no change in perfu sion pressure.
The present results suggest that products of pros taglandin metabolism may mediate the vasocon striction produced by blood in this model. This conclusion is supported by (1) the observations that cyclooxygenase inhibitors effectively prevented the vasoconstriction, and (2) the capability of both ara chidonic acid and known vasoconstrictor prosta glandins (PGE2 and PGF2a) to produce vasocon striction in this preparation. In this study, we tested four structurally dissimilar cyclooxygenase inhib itors (aspirin, indomethacin, ibuprofen, and meclo fanamate), as these drugs may also modulate the activity of other enzyme systems as well as that of cyclooxygenase (Flower, 1974) . The ability of all four inhibitors to prevent the characteristic in- crease in inflow pressure caused by the application of blood thus strengthens the conclusion that the response was mediated by prostaglandins. Our re sults are consistent with those of Linder and Alksne (1978) , who observed that the acute con striction of canine basilar arteries produced by rabbit blood could be attenuated with aspirin treat ment. A similar result was found in a chronic model of subarachnoid hemorrhage by co workers (1979, 1983) , who reported that the cy ciooxygenase inhibitors sudoxicam, piroxicam, meclofenamate, and ibuprofen reduced the occur rence of vascular spasm 24 h after the intracisternal injection of blood. Thus, there is evidence that prostaglandins may play a role in the vascular spasm that occurs in models of both acute and chronic subarachnoid hemorrhage. Supportive evidence for a mechanism involving prostaglandins in this response was obtained from the experiments in which arachidonic acid was ad ministered. Arachidonic acid produced an increase in inflow pressure of a magnitude similar to that ob served with blood. These results are similar to those of others (Chapleau et aI., 1980; Katusic et aI., 1987; White et aI., 1984) who have previously reported that arachidonic acid produces constric tion of isolated basilar arteries. Although we did not measure the concentrations of any prosta glandins or metabolites that may have been synthe sized after arachidonate administration, have shown that isolated cerebral arteries synthesize prostaglandins when incubated with ara chidonic acid. Ta ken together, these data suggest that the vessels of our preparation are capable of producing vasoconstrictor prostaglandins. Also supportive of this interpretation are studies that have shown that cerebral arterial wall PGE2 con centration increases after blood is injected into the subarachnoid space (Maeda et al., 198 1; Walker et al., 1983) .
Finally, the ability of the known cerebral vaso constrictor prostaglandins PGE2 and PGF2u (Allen et al., 1974; Pennink et al., 1972; White et al., 1975) to produce vasoconstriction in this preparation in dicated that these vessels are responsive to exoge nous prostaglandins. Both of these prostaglandins have been shown to be synthesized by bovine (Hagen et aI. , 1979) and canine cerebral arteries (Maeda et al., 198 1) , and increases in their concen trations have been observed in the cerebrospinal fluid of both animals and patients after subarach noic hemorrhage or head injury (Ellis et aI., 198 1; Walker et al. , 1983) .
We also tested the possibility that thromboxane, a potent vasoconstrictor prostaglandin, might be the mediator of the blood-induced vasoconstriction (Ellis et aI., 1977; Kassell et al., 1985) . Imidazole, a thromboxane synthetase inhibitor (Granstrom et aI. , 1983) , however, was ineffective in preventing the blood response, indicating that the vasocon striction was not mediated by thromboxane.
The source of the increased prostaglandin syn- Values are means ± SE; n = 6. a p < 0.05.
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84.8 ± 4.0a 88.5 ± 7.2a 87.7 ± 5.4a thesis (vessels or blood) cannot be determined from the present data. Although it appears that the vessels of this preparation are capable of synthe sizing prostaglandins, it is not clear if they are the source of the prostaglandins that may be producing the blood response. The observation that vasocon striction could again be elicited by blood after any of the four cyclooxygenase inhibitors was removed may signify that the blood, rather than the vessels, was the source of prostaglandin production. Al though some such inhibitors, such as aspirin, have been previously considered to be irreversible inhib itors of prostaglandin cyclooxygenase (Smith and Lands. 1971) . newer information suggests that there may be pools of this enzyme that can be re versibly inhibited or quickly resynthesized (Manku and Horrobin. 1976; Willems et aI. , 1982) . For ex ample, Willems et al. (1982) reported that aspirin inhibited prostaglandin synthesis in both the platelet and endothelial cell, but that the inhibition was reversible in the endothelial cell. The revers ible inhibition observed in our study may thus also signify that the drugs acted on vascular pools of the enzyme that were either reversibly inhibited or re synthesized. and thus, does not rule out the possi bility that the vessels were the prostaglandin source.
In conclusion, we have reported that blood induced constriction of the large cerebral arteries of an isolated canine brain is reversibly inhibited by cyclooxygenase inhibitor drugs. Although specific prostaglandins that might be involved in the con strictor response were not identified, PGE2 and PGF2u constricted vessels of this preparation and might be considered potential mediators. Ta ken to gether, these results support the hypothesis that prostaglandins may mediate the constriction that occurs when blood is topically applied to the vessels of this preparation.
